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The two water-soluble designed platinum(II) complex, [Pt(Oct-dtc)(bpy)]NO3 (Oct-dtc = Octyldithiocarbamate and bpy =
2,2  -bipyridine) and palladium(II) complex, [Pd(Oct-dtc)(bpy)]NO3, have been synthesized and characterized by elemental
analyses, molar conductivity measurements, IR, 1H NMR, and electronic spectra studies. Studies of antitumor activity of these
complexes against human cell tumor lines (K562) have been carried out. They show Ic50 values lower than that of cisplatin. The
complexes have been investigated for their interaction with calf thymus DNA (CT-DNA) by utilizing the electronic absorption
spectroscopy, ﬂuorescence spectra, and ethidium bromide displacement and gel ﬁltration techniques. Both of these water-soluble
complexesboundcooperativelyandintercalativelytotheCT-DNAatverylowconcentrations.Severalbindingandthermodynamic
parameters are also described.
1.Introduction
In order to reduce the toxicity of cisplatin, that is, the well-
known anticancer drug, and modulate its activity, a new
strategy is the design of novel metal complexes containing
N and S donor ligands [1–3]. This interest has probably
initiated from detoxicant properties of sulfur-containing
ligands against heavy metal intoxication [4]. As an example
is the use of sodium diethyldithiocarbamate (DDTC) in
the treatment of patients with acute poisoning of nickel
carbonyl, arsenic, and thallium [5]. A further interest in
this chelating ligand has arisen due to its highly selective
use to protect a variety of animal species from renal, gas-
trointestinal, and bone marrow toxicity, induced by cisplatin
without inhibition of cisplatin’s antitumor eﬀect [6–9]. In
addition, diethyldithiocarbamate has remarkable property of
reversing platinum binding to macromolecules responsible
for host toxicity. However, it does not interfere with the
tumoricidal Pt-DNA interaction in the tumor cell. Thus, the
protective action of the dithiocarbamate against the toxicity
of cisplatin seems to be the formation of its stable platinum
dithiocarbamate complexes [7, 10].
A large number of analogs of cisplatin have been tested,
and it has been reported that many active complexes could
react with cell DNA and inhibit its synthesis [11–14]. Re-
cently, signiﬁcant attention has been focused on the DNA
binding properties of dithiocarbamate metal complexes
[15–17] and several dithiocarbamate derivatives have been
investigated as potential biologically active agents [18–23].
Among which platinum and palladium complexes of dithio-
carbamates have gained considerable interest due-to-their
potential antitumor properties [24–29].
It has also known that dithiocarbamate complexes of
[M(NN)(SS)] type, with diimine (NN) as a π-electron ac-
ceptor and dithiocarbamate (SS) as an electron donor,
exhibit intramolecular mixed metal ligand to ligand charge
transfer bands [30, 31]. This band appears in a region where2 Bioinorganic Chemistry and Applications
CT-DNA has no absorption and thus has been widely used
for the absorption spectrophotometric binding studies.
In this work, we have chosen a bioactive octyldithio-
carbamate ligand whose structure not only resembles a
great number of antibacterial, antiviral, anthelmintic, and
insecticidal agent, but also can be used as inhibitor of
cisplatin-induced nephrotoxicity [32] while as diimine we
have employed 2,2 -bipyridine (bpy) whose structure adopts
a planar conformation when it chelates to Pt(II) or Pd(II)
center [33], and thus can intercalate in CT-DNA. These
complexes have been tested against human cell tumor line
K562. In order to conﬁrm the mode of binding of these
complexes to CT-DNA, detailed interaction studies of them
with CT-DNA are attempted.
2. Experimental
2.1. Materials and Methods. Octylamine and carbon disul-
ﬁde were purchased from Aldrich (England). Palladium(II)
chloride was obtained from Fluka (Switzerland). Potassium
tetrachloroplatinate,2,2 -bipyridine,highlypolymerizedcalf
thymusDNAsodiumsalt,andTris-HClbuﬀerwereobtained
from Merck (Germany). Other chemicals used were of an-
alytical reagent or higher purity grade. [Pt(bpy)Cl2]a n d
[Pd(bpy)Cl2] were prepared by the procedures described
in the literature [34]. Solvents used were of reagent grade
and puriﬁed before use by the standard methods. All the
experiments involving interaction of the complexes with CT-
DNA were performed in Tris-HCl buﬀer (20mM) of pH =
7.0 medium containing 20mM NaCl. Monitoring the ratio
of the absorbance at 260 to that of 280nm checks purity
of CT-DNA. The solution gave a ratio of >1.8 at A260/A280,
indicating that CT-DNA is suﬃciently free from protein
[35, 36]. The CT-DNA concentration per nucleotide was
determined by absorption spectroscopy using the known
molar extinction coeﬃcient value of 6600M−1cm-1 at
260nm [37].
Electronicabsorptionspectraofthetitlemetalcomplexes
were measured on a JAS.CO UV/Vis-7850 recording spec-
trophotometer. Infrared spectra of the metal complexes were
recorded on a JAS.CO-460 Plus FT-IR spectrophotometer in
the range of 4000–400cm−1 in KBr pellets. Microchemical
analysis of carbon, hydrogen, and nitrogen for the complexes
were carried out on a Herause CHNO-RAPID elemental
analyzer. 1H NMR spectra were recorded on a Brucker DRX-
500 Avance spectrometer at 500MHz in DMSO-d6 using
tetramethylsilane as internal reference. Fluorescence inten-
sity measurements were carried out on a Hitachi spectroﬂu-
orimeter model MPF-4. Melting point was measured on
a Unimelt capillary melting point apparatus and reported
uncorrected. Conductivity measurements of the above plat-
inum and palladium complexes were carried out on a
Systronics conductivity bridge 305, using a conductivity cell
ofcellconstant1.0.Doublydistilledwaterwasusedassolvent
all along.
2.2. Synthesis of Octyldithiocarbamate Sodium Salt (Oct-
dtcNa). This ligand was synthesized by the method as
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Scheme 1: Proposed structures and proton NMR numbering
schemes of [Pt/Pd(bpy)(Oct-dtc)]NO3 complexes.
described earlier [15], except that butylamine was re-
placed by octylamine (8.33mL, 50mmol). The yield was
8.51g (75%); m.p. 173◦C. Anal. Calcd. For C9H18NS2Na
(227g/mol): C, 47.58; H, 7.93; N, 6.17%. Found: C, 47.64;
H, 7.92; N, 6.16%. Solid state IR spectroscopy of the above
ligand shows three main characteristic bands at 1491, 930,
and 3171cm−1 assigned to ν (N-CSS) and ν (SCS) and ν (N-
H) stretching modes, respectively, [16]. 1H NMR (500MHz,
DMSO-d6, ppm, m = multiplet and sb = singlet broad): 0.84
(m, 3H, H-a), 1.24 (m, 10H, H-b), 1.41 (m, 2H, H-c), 3.31
(m, 2H, H-d), and 7.98 (sb, -NH-) (Scheme 1).
2.3. Synthesis of [Pt (Oct-dtc)(bpy)]NO3. This complex was
synthesized following our previous procedure [15], except
that But-dtcNa was replaced by Oct-dtcNa. The yield was
0.475g,77%andthecomplexdecomposesat197◦C.Analysis
calculated for C19H26 N4O3S2Pt (617): C, 36.95; H, 4.21; N,
9.08%. found: C, 36.90; H, 4.19; N, 9.07%. solid state FT-IR
spectroscopyoftheabovecomplexshowsthreecharacteristic
stretching bands at 1035, 1535 and 2945cm−1 assigned to
ν(SCS), ν(N-CSS) and ν(N-H) modes, respectively [20, 38].
The sharp band at 1385cm−1 is assigned to uncoordinated
NO3
− ion [39]. 1H NMR (500MHz, DMSO-d6, ppm, Sb=
singlet broad, t = triplet, d = doublet, q = quartet and m =
multiplet [40]: 0.85 (t, 3H, H-a), 1.27 (m, 10H, H-b), 1.62
(t, 2H, H-c), 3.49 (t, 2H, H-d), 7.75 (t, 2H, H-4,4 ), 8.45 (t,
2H, H-5,5 ), 8.52 (q, 2H, H-3,3 ), 8.70 (d, 2H, H-6,6 ), and
11.53 (sb, 1H, H-e), (Scheme 1). Molar conductance of the
complex is 91.78 Ω−1 mol−1 cm2 indicating 1:1 electrolytesBioinorganic Chemistry and Applications 3
[41]. Electronic spectra exhibit ﬁve bands. The band at 364
(ε = 3.56) is assigned to MLCT and the other bands at 321
(ε = 6.72), 310 (ε = 5.42), 285 (ε = 13.69) and at 202 (ε =
27.41) may be due to ﬁrst, second, and higher internal π-π∗
transitions of 2,2 -bipyridine as well as dithiocarbamate li-
gands [15].
2.4. Synthesis of [Pd(Oct-dtc)(bpy)]NO3. This complex was
prepared by a similar method to that of [Pt(bpy)(Oct-dtc)]
NO3. Yield was 0.360g, 68% and decomposes at 178◦C.
Analysis calculated for C19H26N4O3S2Pd (528): C, 43.18;
H, 4.92; N, 10.61%. Found: C, 43.17; H, 4.93; N, 10.60%.
Solid state FT-IR spectroscopy of the complex shows three
characteristic stretching bands at 1539, 1030, and 2987cm−1
assigned to ν(N-CSS), ν(SCS), and ν(N-H) modes, respec-
tively, [20, 38]. The sharp band at 1385cm−1 is assigned to
uncoordinated NO
−
3 ion [39]. 1H NMR (500MHz, DMSO-
d6, ppm, sb = singlet broad, t = triplet, q = quartet, and
m = multiplet (40): 0.82 (t, 3H, H-a), 1.24 (m, 10H, H-
b), 1.57 (m, 2H, H-c), 3.45 (t, 2H, H-d), 7.69 (m, 2H, H-
4,4 ), 8.15 (q, 2H, H-5,5 ), 8.26 (m, 2H, H-3,3 ), 8.51 (q,
2H, H-6,6 ), and 11.21 (sb, 1H, H-e) (Scheme 1). Molar
conductance of the complex is 97 Ω−1mol−1 cm2 indicating
1:1electrolytes[41]. Electronic spectra exhibit four bands.
The bands at 318 (ε = 1.88) and 307 (ε = 1.82) are assigned
to MLCT, and the other bands at 247 (ε = 6.50) and 203
(ε = 3.78) may be assigned to ﬁrst and second intraligand
π-π∗ transition of 2,2 -bipyridine ligand as well as −CSS−
group of dithiocarbamate ligand [15].
2.5. Cytotoxic Studies. The procedure for cytotoxic studies
of the [Pt(bpy)(Oct-dtc)]NO3 and [Pd(bpy)(Oct-dtc)]NO3
was similar to that reported earlier [15]. Here, also 1 × 104
cells per mL of K562 chronic myelogenous leukemia were
used in Tris-HCl buﬀer solution of PH 7.0.
2.6. Metal Complexes—DNA-Binding Studies. [Pt/Pd(bpy)
(Oct-dtc)]NO3 complexes were interacted with calf thymus
DNA in Tris-HCl buﬀer (20mM, PH = 7.0) containing
20mM sodium chloride. The procedure followed to deter-
mine binding and thermodynamic parameters were similar
to what was reported earlier [16]. The stock solutions
of the complexes (0.5mmol/L) and CT-DNA (4mg/mL)
were made in the same buﬀer. The DNA-metal complex
solutions were incubated at 300K and 310K, and, then,
the spectrophotometric reading at λmax of the complexes
(321nm for Pt(II) complex and 305nm for pd(II) complex),
where CT-DNA has no absorption, were measured. Using
trial and error method, the incubation time for solutions
of DNA-metal complexes at 300K and 310K was found to
be 6h. No further changes were observed in the absorbance
readingafterlongerincubation.Alltheexperimentsrepeated
to get the constant results.
3. Results andDiscussion
The compounds correspond to the composition Oct-dtcNa,
[Pd(bpy)(Oct-dtc)]NO3 and [Pt(bpy)(Oct-dtc)]NO3,w h e r e
bpy = 2,2 -bipyridine, and Oct-dtc = octyldithiocarbamato
ligands were prepared and characterized by chemical analy-
sis, conductance measurements, ultraviolet-visible, infrared
and, 1H NMR spectroscopic methods. These analytical data
of the complexes are given in experimental section and the
proposed structure in Scheme 1. Cytotoxicity and detailed
calf thymus DNA-binding studies of these water-soluble
complexes have been studied.
3.1. Cytotoxic Measurement of the Metal Complexes. [Pt/Pd
(bpy)(Oct-dtc)]NO3 complexes were screened for their anti-
tumor activities against K562 chronic myelogenous leukemia
cells [15]. These cells were maintained in RPMI 1640 me-
dium supplemented with 10% FCS in a humidiﬁed incu-
bator (310K and 5% CO2). The cells were then grown in
RPMI medium supplemented with L-glutamine (2mM),
streptomycin and penicillin (5μg/mL), and 10% heat-
inactivated fetal calf serum, at 310K under a 5% CO2/95%
air atmosphere. In this study, the harvested cells were seeded
into 96-well plate (1 × 104 cell/mL) with various concentra-
tions of metal complexes ranging from 0 to 0.25mM and
incubated for 24h [42]. The 50% cytotoxic concentrations
(Ic50) of the Pt(II) and Pd(II) complexes were determined
to be 0.0017 and 0.007mM, respectively (Figure 1 for pt(II)
complex and the inset for Pd(II) complex). As shown in
Figure 1, cell growing after 24h was signiﬁcantly reduced
in the presence of various concentrations of the metal
complexes. Furthermore, Ic50 value of cisplatin under the
same experimental conditions was determined. This value
(0.154mM) is much higher as compared to the Ic50 value
of the above two complexes. However, the Ic50 values of
these complexes are comparable with those of our analogous
Pt(II)andPd(II)dithiocarbamatecomplexesreportedearlier
[15–17]. This procedure for growth inhibition studies of the
metal complexes established that the cell DNA is the target
biomolecule for these complexes [39].
3.2. DNA-Binding Studies
3.2.1. CT-DNA Denaturation Data and Evaluation of Ther-
modynamic Parameters. Absorption spectroscopy is one of
the most useful techniques to study the binding of any drug
to DNA [43–46]. The procedure followed was similar to that
reported earlier [47, 48]. These experiments were carried
out separately at two temperatures of 300K and 310K in
Tris-HCl buﬀer medium. The absorbance at 260nm was
monitored for either CT-DNA (0.129mM and 0.115mM for
experiments carried out for Pt(II) complex and 0.197mM
and 0.187mM for Pd(II) complex at 300K and 310K, resp.)
or mixtures of CT-DNA with increasing concentrations of
Pt(II) and Pd(II) complexes (0.0028mM to 0.00130mM and
0.0028mM to 0.114mM for Pt(II) complex and 0.0068mM
to 0.140mM and 0.0028mM to 0.113mM for Pd(II)
complex at 300K and 310K, resp.). Also the absorbance
of CT-DNA and mixture of DNA-Pt(II)/Pd(II) complexes
was measured at 640nm to eliminate the interference of
turbidity.
The proﬁles of denaturation of CT-DNA by [Pt(Oct-
dtc)(bpy)]NO3 and [Pd(Oct-dtc)(bpy)]NO3 are shown in4 Bioinorganic Chemistry and Applications
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Figure1:ThegrowthsuppressionactivityofthePt(II)complexand
the inset for Pd(II) complex on K562 cell line assessed using MTT
assay as described in Section 2.1. The tumor cells were incubated
with varying concentrations of the complexes for 24h.
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Figure 2: The changes of absorbance of CT-DNA at λmax = 260nm
due to increasing the total concentration of [Pt(bpy)(Oct-dtc)]NO3
and the inset for [Pd(bpy)(Oct-dtc)]NO3,[ L]t,a tc o n s t a n tt e m p e r -
atures of 300K and 310K.
Figure 2.A sFigure 2 shows, the concentration of metal
complexes in the midpoint of transition, [L]1/2, at 300K
is 0.065mM and at 310K is 0.059mM for Pt(II) complex
and 0.093mM at 300K and 0.086mM at 310K for Pd(II)
complex. One of the most important observations made in
this research is the extraordinary low values of [L]1/2 for
[Pt(Oct-dtc)(bpy)]NO3 and [Pd(Oct-dtc)(bpy)]NO3 com-
plexes. This means that the complexes can denature CT-
DNA at extremely low concentrations, and if these will be
used as anticancer agent, quite low doses will be needed,
which may have fewer side eﬀects. These values are lower or
comparable with [L]1/2 values of binding of analogous com-
plexes [Pt/Pd(bpy)(Et-dtc)]NO3 [15] and [Pt/Pd(bpy)(Bu-
dtc)]NO3 [16] with CT-DNA.
It is noticeable that absorbance of DNA at 260nm should
increase in presence of increasing amount of each metal
complex (denaturant agent). This is true for palladium
complex (Figure 2). However, the opposite trend is observed
for the platinum analog. Keeping in mind that platinum
c o m p l e x e sr e a c ta b o u t1 0 5–106 times slower than palladium
complexes [49, 50], the decrease in the absorbance at 260nm
with the increase of the amount of Pt(II) complex added
to CT-DNA may be due to (i) a possibility that interaction
between CT-DNA and the metal complex causes the double
helix of CT-DNA to become more straight leading to stack-
ing; this stacking may cause conformational changes lead-
ing to a sort of denaturation or (ii) each strand after
denaturation gets associated in a more stacked structure
and (iii) metal complex slips into the helix and masks the
hydrophobic bases leading to a decrease in absorbance. As
will be seen in the later part of this paper, the [Pt(Oct-
dtc)(bpy)]NO3 and [Pd(Oct-dtc)(bpy)]NO3 complexes can
bind CT-DNA taking the mode of intercalation. This mode
of binding supports the above three hypotheses.
Using the CT-DNA denaturation plots (Figure 2)a n d
Pace method [50], the value of K, that is, unfolding
equilibrium constant and ΔG◦, unfolding free energy of CT-
DNA, at two temperatures of 300K and at 310K in the
presenceofPt(II)andPd(II)complexeshavebeencalculated.
In this method, Pace had assumed two-state mechanism,
nature and denature, and then calculated unfolding free
energy of DNA, that is, (ΔG◦) by using (1):
K =
AN −Aobs
A0bs −AD
,
ΔG◦ =− RT LnK,
(1)
where Aobs is absorbance readings in transition region
and AN and AD are absorbance readings of nature and
denatured conformation of DNA, respectively. A straight
line is observed when the values of ΔG◦ are plotted against
the concentrations of each metal complex in the transition
region at 300K and at 310K. These plots are shown in
Figure 3 for Pt(II) complex and the inset for Pd(II) complex.
The equation for these lines can be written as follow [51]:
ΔG
◦ = ΔG
◦
(H2O) −m

complex

. (2)
Here, the values of ΔG
◦
(H2O) for each curve are measured
from the intercept on ordinate of the plots and it is
conformational stability of DNA in the absence of metal
complex. m (the slope of each curve in the same plots) is
a measure of the metal complex ability to denature CT-
DNA and is summarized in Table 1.T h ev a l u e so fm for the
above complexes are much higher than those of Pt(II) and
Pd(II) complexes reported earlier [15–17], which indicate
the higher ability of this Pt(II) and Pd(II) complexes to
denature CT-DNA. As we know, the higher the values of
ΔG◦, the larger the conformational stability of CT-DNA.
However, the values of ΔG◦ (Table 1) are decreased by
increasing the temperature. This is as expected because, in
general, the decrease in ΔG
◦
(H2O) value is the main reason
for the decrease in CT-DNA stability [52]. Molar enthalpyBioinorganic Chemistry and Applications 5
Table 1: Thermodynamic parameters of CT-DNA denaturation by palladium(II) and platinum(II) complexes.
Compound Temperature (K) am (kJ/mol) (mmol/L)−1b ΔG
◦
(H2O) (kJ/molK) cΔH
◦
(H2O) (kJ/mol) dΔS
◦
(H2O) (kJ/mol)
[Pt(bpy)(Oct-dtc)]NO3
300 123 8.30 34.5 0.08
310 133 7.40
[Pd(bpy)(Oct-dtc)]NO3
300 195 13.44 28.09 0.05
310 218 12.93
aMeasure of the metal complex ability to denature CT-DNA.
bConformational stability of CT-DNA in the absence of metal complex.
cThe heat needed for CT-DNA denaturation in the absence of metal complex.
dThe entropy of CT-DNA denaturation by metal complex.
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Figure 3: The molar Gibbs free energies of unfolding (ΔG◦ versus
[L]t)ofCT-DNAinthepresenceof[Pt(bpy)(Oct-dtc)]NO3 andthe
inset for [Pd(bpy)(Oct-dtc)]NO3.
of CT-DNA denaturation in absence of Pt(II) and Pd(II)
complexes, ΔH
◦
(H2O), is another important thermodynamic
parameter. To ﬁnd this, we calculated the molar enthalpy of
CT-DNA denaturation in presence of the metal complexes,
ΔH
◦
conformation or ΔH
◦
denaturation, in the range of two tempera-
tures using Gibbs-Helmholtz equation [53]. On plotting the
values of these enthalpies versus the concentration of metal
complexes, straight lines will be obtained which are shown
in Figure 4 for [Pt(Oct-dtc)(bpy)]NO3 and the inset for
[Pd(Oct-dtc)(bpy)]NO3 complexes. Intrapolation of these
lines (intercept on ordinate, i.e., absence of metal complexes)
gives the values of ΔH
◦
(H2O) (Table 1). These plots show that
in the range of 300–310K the changes in the enthalpies in
presence of Pt(II) and Pd(II) complexes are ascending. These
observations indicate that, on increasing the concentration
of Pt(II) and Pd(II) complexes, the stability of CT-DNA
is increased. Moreover, the entropy of CT-DNA unfolding
by Pt(II) and Pd(II) complexes ΔS
◦
(H2O) has been calculated
using equation ΔG = ΔH − TΔS and the data are given
in Table 1. These data show that the metal-DNA complexes
are more disordered than those of native CT-DNA, because
the entropy changes are positive for Pt(II)- or Pd(II)-
DNA complexes in the denaturation processes of CT-DNA
0
50
100
150
200
250
300
350
400
0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8
Δ
H
◦
c
o
n
(
k
J
/
m
o
l
)
[L]t (mM)
0
50
100
150
200
250
300
0 0.2 0.4 0.6
Δ
H
◦
c
o
n
(
k
J
/
m
o
l
)
[L]t (mM)
Figure 4: The molar enthalpies of CT-DNA denaturation in
the interaction with [Pt(bpy)(Oct-dtc)]NO3 and the inset for
[Pd(bpy)(Oct-dtc)]NO3 complexes in the range of 300K to 310K.
(Table 1). The above thermodynamic parameters agree well
with those we have reported for [Pt/Pd(bpy)(Et-dtc)]NO3
[15] and [Pt/Pd(bpy)(Bu-dtc)]NO3 [16]c o m p l e x e s .
3.2.2. UV-Vis Spectral Studies and Evaluation of Binding
Parameters. A ﬁxed amount of [Pt(Oct-dtc)(bpy)]NO3 and
[Pd(Oct-dtc)(bpy)]NO3 complexes (0.006mM for Pt(II)
complex and 0.025mM and 0.037mM for Pd(II) com-
plex at 300K and 310K, resp.) was titrated with increas-
ing amounts of CT-DNA (0.010mM to 0.081mM and
0.010mM to 0.076mM for Pt(II) complex and 0.024mM
to 0.089mM and 0.061 to 0.114mM for Pd(II) complex
at 300K and 310K, resp.). In this experiment, the changes
in the absorbance, ΔA, of metal complexes at 321nm
for Pt(II) complex and 305nm for Pd(II) complex were
calculated by subtracting the absorbance reading of DNA-
metal complexes solution from absorbance reading of free
metal complexes solution. The maximum ΔA (ΔAmax), that
is, change in the absorbance when all binding sites on CT-
D N Aw e r eo c c u p i e db ym e t a lc o m p l e x( Figure 5, intercept
on ordinate) is 0.021 and 0.028 for Pt(II) complex and
0.035 and 0.058 for Pd(II) complex at 300K and 310K,
respectively. These values of ΔAmax were used to calculate
the concentration of bound metal complexes to CT-DNA in
the next experiment: a ﬁxed amount of CT-DNA (0.023mM6 Bioinorganic Chemistry and Applications
Table 2: Values of ΔAmax and binding parameters in the Hill equation for interaction between Pt(II) and Pd(II) complexes and CT-DNA in
20 mmol/L Tris-HCl buﬀer and pH 7.0.
Compound Temperature (K) aΔAmax
bg cK× 104 (M)−1d n eError
[Pt(bpy)(Oct-dtc)]NO3
300 0.021 6 4.01 1.87 0.005
310 0.028 1.10 1.36 0.007
[Pd(bpy)(Oct-dtc)]NO3
300 0.035 6 5.28 5.92 0.13
310 0.058 5.86 6.18 0.14
aChange in the absorbance when all the binding sites on CT-DNA were occupied by metal complex.
bThe number of binding sites per 1000 nucleotides.
cThe apparent binding constant.
dThe Hill coeﬃcient (as a criterion of cooperativity).
eMaximum error between theoretical and experimental values of ν.
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Figure 5: The changes in the absorbance of ﬁxed amount of each
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at 300K and 310K. The linear plot of the reciprocal of ΔA versus
the reciprocal of [DNA] for [Pt(bpy)(Oct-dtc)]NO3 and the inset
for [Pd(bpy)(Oct-dtc)]NO3.
for Pt(II) complex and 0.001mM for Pd(II) complex) was
titrated with varying concentrations of Pt(II) and Pd(II)
complexes(10to0.025mMand0.002to0.020mMforPt(II)
complex and 0.017 to 0.022mM and 0.018 to 0.022mM
for Pd(II) complex at 300K and 310K, resp.). Now, the
concentrations of metal complexes bound to CT-DNA, [L]b,
and the concentration of free metal complex, [L]f,a r e
calculated using the relationship
[L]b = ΔA [L]t/ΔAmax,
[L]f = [L]t −[L]b,
(3)
where [L]t is the maximum concentration of metal complex
addedtosaturateallthebindingsitesofCT-DNA.TheScatc-
hard plots were obtained separately at 300K and 310K by
plotting ν/[L]t versus ν of the relationship ν = [L]b/[DNA]t
(Figure 6). These plots are curvilinear concave downwards,
suggesting cooperative binding [54]. Similar cooperativity in
binding of analogous complexes with CT-DNA has also been
observed [15, 55].
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Figure 6: Scatchard plots for binding of [Pt(bpy)(Oct-dtc)]NO3
and the inset for [Pd(bpy)(Oct-dtc)]NO3 to CT-DNA.
Onsubstitutingtheaboveexperimentaldata(νand[L]f)
in Hill equation,
ν =
g

K[L]f
n

1+(K [L]f
n,( 4 )
we get a series of equations with unknown binding param-
eters n, K,a n dg. Using Eureka software, the theoretical
valuesoftheseparametershavebeendeduced.Theresultsare
shown in Table 2. These results are comparable with those
of 2,2 -bipyridine-platinum and -palladium complexes of
dithiocarbamates as reported earlier [15, 16]. The apparent
binding constants of two complexes obtained were 4.01 ×
104 M−1 at 300K and 1.10 × 104 M−1 at 310K for Pt(II)
complex and 5.28 × 104 M−1 at 300K and 5.86 × 104 M−1 at
310KforPd(II)complex.Thevaluesarecomparabletothose
of CT-DNA intercalators [Pd(dmphen)CO3]·H2O1 . 6 ×
104 M−1 [56] and [Cu(GFL)(A1)Cl]·5H2O2 . 4 5× 103 M−1
[57]a n d[ R u ( b p y ) 2(PPIP)]
2+
2 4.3 × 104 M−1 [58]a n d[ R u
(dmb)2(NMIP)]2 5.46 × 103 M−1 [59]. Obviously, these
thermodynamical characteristics suggest that the two com-
plexes intercalatively bind to CT-DNA, involving a strong
stacking interaction between the aromatic chromophore and
the base pairs of the DNA [60]. Similar results were obtainedBioinorganic Chemistry and Applications 7
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Figure 7: Binding isotherm plots for [Pt(bpy)(Oct-dtc)]NO3 and
the inset for [Pd(bpy)(Oct-dtc)]NO3 in the interaction with CT-
DNA.
for [Pd(ddtc) (bpy)]NO3·H2O[ 7]. The maximum errors
between experimental and theoretical values of ν are also
shown in Table 2, which are quite low.
Knowing the experimental (dots) and theoretical (lines)
values of ν in the Scatchard plots and their superimposability
on each other, these values of ν were plotted versus the
values of ln[L]f. The results are sigmoidal curves and are
shown in Figure 7 for Pt(II) complex and the inset for Pd(II)
complex at 300K and 310K. These plots indicate positive
cooperative binding at both temperatures for the complexes.
The area under these plots of binding isotherms were found
and by using Wyman-Jons equation [61], Kapp, ΔG
◦
b and
ΔH
◦
b were calculated at 300K and 310K for each particular
ν. Plots of the values of ΔH
◦
b versus the values of [L]f are
shown in Figure 8 for [Pt(Oct-dtc)(bpy)]NO3 and the inset
for [Pd(Oct-dtc)(bpy)]NO3 at 300K. These plots show that,
at very low value of [L]f (∼0.05mM for Pt(II) complex
and ∼0.01mM for Pd(II) complex), available binding sites
for the metal complexes on CT-DNA have been saturated.
This may be due to high interaction aﬃnity of CT-DNA for
[Pt(Oct-dtc)(bpy)]NO3 and [Pd(Oct-dtc)(bpy)]NO3 com-
plexes [61, 62].
3.3. Gel Filtration. [Pt(Oct-dtc)(bpy)]NO3 and [Pd(Oct-
dtc)(bpy)]NO3 complexes (0.125mM and 0.050mM, resp.)
were incubated with CT-DNA (0.223mM for Pt(II) complex
and 0.249mM for Pd(II) complex) for 6h at 300K in Tris-
HCl buﬀer, pH 7.0. DNA-metal complexes were then passed
throughaSephadex G-25columnequilibratedwiththesame
buﬀer. The elusion of the column fraction of 2.0mL was
monitored at 321nm and 260nm for DNA-Pt(II) complex
system and at 305nm and 260nm for DNA-Pd(II) complex
system. These results are given in Figure 9 for Pt(II) complex
and the inset for Pd(II) complex. This plot shows that the
peak obtained for the two wavelengths are not resolved and
suggests that CT-DNA has not separated from the metal
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Figure 8: Molar enthalpies of binding in the interaction
between CT-DNA and [Pt(bpy)(Oct-dtc)]NO3 and the inset for
[Pd(bpy)(Oct-dtc)]NO3 versus free concentrations of complexes at
pH 7.0 and 300K.
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Figure 9: Gel chromatograms of [Pt(bpy)(Oct-dtc)]NO3 and the
inset for [Pd(bpy)(Oct-dtc)]NO3 obtained on Sephadex G-25
column.
complexes. Thus, it implies that the binding between CT-
DNA and the metal complexes is not reversible under such
circumstances. This is due to the fact that if the interaction
between CT-DNA and metal complexes was weak, the CT-
DNA should have come out of the column separately [63].
4. Conclusions
Theaboveworkdescribesthesynthesis,characterization,and
c y t o t o x i cs t u d i e so fan o v e la n dw a t e r - s o l u b l ep l a t i n u m ( I I )
and palladium(II) complexes possessing a planar aromatic
ligand for intercalation and a dithiocarbamate ligand to
avoid its renal damage. Ic50 values of these complexes are
much lower than those of cisplatin. Furthermore, detailed
interactionstudiesofthecomplexeswithCT-DNAhavebeen
carried out. They cooperatively bind to DNA through inter-
calation mode and unexpectedly denature DNA at extremely
low concentration. Determinations of several binding and
thermodynamic parameters have also been attempted. They8 Bioinorganic Chemistry and Applications
Table 3: Binding parameters for the eﬀect of platinum and palladium complexes on the ﬂuorescence of EBr in the presence of CT-DNA.
Compound arf
bK× 105 (M)−1c n
[Pt/Pd(bpy)(Oct-dtc)]NO3 0.00 1.68
0.0078
[Pt(bpy)(Oct-dtc)]NO3
0.55 1.04
1.185 0.72
1.85 0.55
[Pd(bpy)(Oct-dtc)]NO3
0.2 1.08
0.0078 0.58 0.78
0.92 0.56
aFormal ratio of metal complex to nucleotide concentration.
bAssociation constant.
cNumber of binding sites (n)p e rn u c l e o t i d e .
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Figure 10: Fluorescence emission spectra of interacted EB-DNA
in the absence (1) and presence of diﬀerent concentrations of
[Pt(bpy)(Oct-dtc)]NO3 and the inset for [Pd(bpy)(Oct-dtc)]NO3:
33 μM( 2 ) ,7 1μ (3), and 111μM( 4 )a n d1 2μM( 2 ) ,3 5μM( 3 ) ,a n d
55μM (4), respectively, at 300K.
may be helpful to understand the mechanism of the inter-
action between these complex and nucleic acid that must be
quite diﬀerent from that of cisplatin.
4.1. Competitive Binding between Ethidium Bromide (EB) and
Pt(II)/Pd(II) Complexes for CT-DNA. No ﬂuorescence was
observed for aqueous solution of above Pt(II) and Pd(II)
complexes alone or in the presence of calf thymus DNA.
So, the binding of Pt(II) and Pd(II) complexes with CT-
DNA cannot be directly presented in the emission spectra.
It has been studied by competitive EB binding experiments
[64, 65]. The ﬂuorescence of EB is greatly enhanced upon
intercalation to DNA. The eﬀect of platinum(II)-2,2 -
bipyridine and palladium(II)-2,2 -bipyridine complexes of
octyldithiocarbamate on the ﬂuorescence intensity of DNA-
EB complexes was studied to get the mode of their binding
to CT-DNA. Figure 10 shows the eﬀect of Pt(II) and Pd(II)
complexes (33μM, 71μM and 111μM for Pt(II) complex
and 12μM, 35μMa n d5 5μM for Pd(II) complex) on ﬂuo-
rescence spectrum of solution containing CT-DNA (60μM)
and EB (2μM). It is seen that increasing the concentration
of the Pt(II)/Pd(II) complexes results in a gradual decrease
in ﬂuorescence intensity of DNA-EB solution, without
eﬀectinganyperceptibleshiftsinﬂuorescenceλmax.Itfurther
proves the interaction between these complexes and DNA
molecules. A similar ﬂuorescence quenching behavior was
observed for analogous Pt(II)/Pd(II) complexes reported
earlier [47, 48].
Further studies to characterize the mode of binding
of [Pt(Oct-dtc)(bpy)]NO3 and [Pd(Oct-dtc)(bpy)]NO3 to
DNA were carried out [66, 67]. The number of EB molecules
intercalated to CT-DNA in presence of diﬀerent concen-
trations of the Pt(II) complex and Pd(II) complex was
calculated using Scatchard analysis [68]. In this experiment,
the wavelengths of excitation and emission were set at
540nm and 700nm, respectively, with both having 0.5nm
slit widths. Solutions of CT-DNA, EB, and metal complexes
were prepared in Tris-HCl buﬀer of pH 7.0. In this medium-
solutions of Pt(II) complex and Pd(II) complex were inter-
acted with CT-DNA by incubating them at 300K and 310K
for 6h; appropriate amount of EB was added to them
and further incubated at room temperature (300K) for 6h
and ﬁnally processed for ﬂuorescence spectral measurement.
Saturation curves of ﬂuorescence intensity for [Pt/Pd(Oct-
dtc)(bpy)]+-DNA systems at diﬀerent rf values (0.55, 1.18,
and 1.85 for Pt(II) complex and 0.2, 0.58 and 0.92 for Pd(II)
complex) in presence of increasing concentrations of EB (2,
4,...,20μM)wereobtained.TheﬂuorescenceScatchardplots
obtained for binding of EB to CT-DNA in absence ( )a n d
presence (♦, Δ,a n d◦) of various concentration of Pt(II)
and Pd(II) (inset) complexes were shown in Figure 11. This
ﬁgure shows that the complexes inhibit competitively the EB
binding to CT-DNA (type A behavior) [68], where number
ofbindingsitesn(interceptontheabscissa)remainsconstant
and the slope of the graphs that is Kapp (apparent association
constant) decreases with increasing the concentrations of
Pt(II) and Pd(II) complexes (Table 3). This implies that
the [Pt/Pd(Oct-dtc)(bpy)]NO3 complexes are intercalating
in CT-DNA and thereby competing for intercalation sites
o c c u p i e db yE B .T h ev a l u e so fKapp and n, the number of
binding sites per nucleotide, are listed in Table 3. These data
suggested that the interaction of the [Pd(Oct-dtc)(bpy)]NO3
complex with CT-DNA was stronger than that of [Pt(Oct-
dtc)(bpy)]NO3 complex, which were consistent with the
above absorption spectral results. Compare their Kapp values
with those of other known CT-DNA-intercalative complexes
which possess analogical structure; the Pd(II) complexes inBioinorganic Chemistry and Applications 9
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Figure 11: Competition between [Pt(bpy)(Oct-dtc)]NO3 and the
inset for [Pd(bpy)(Oct-dtc)]NO3 with ethidium bromide for the
binding sites of DNA (Scatchard plot). In curve no. 1, Scatchard
plot was obtained with calf thymus DNA alone. Its concentration
was 60μM. In curves nos. 2, 3, and 4, respectively, 33μM, 71μM,
and 111μMf o rP t ( I I )c o m p l e xa n d1 2 μM, 35μM, and 55μM,
for Pd(II) complex were added, corresponding to molar ratio
[complex]/[DNA]of0.55,1.18,and1.85forPt(II)complexand0.2,
0.58, and 0.92 for Pd(II) complex. Solutions were in 20mM NaCl
and 20mM Tris-HCl (pH 7.0). Experiments were done at room
temperature.
our paper have similar or stronger aﬃnities with CT-DNA
[17]. Similar modes of binding seem to be involved in other
complexes [52, 69].
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